Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial.
Cox RJ, Pedersen G, Madhun AS, Svindland S, Sævik M, Breakwell L, Hoschler K, Willemsen M, Campitelli L, Nøstbakken JK, Weverling GJ, Klap J, McCullough KC, Zambon M, Kompier R, Sjursen H. Cox RJ, et al. Among authors: zambon m. Vaccine. 2011 Oct 19;29(45):8049-59. doi: 10.1016/j.vaccine.2011.08.042. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864624 Clinical Trial.
Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group. Ampofo WK, et al. Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3. Vaccine. 2015. PMID: 26148877 Free article.
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results.
Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Johnston J, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Mullett D, Gallagher N, Sinnathamby M, Yonova I, Moore C, McMenamin J, de Lusignan S, Zambon M. Pebody R, et al. Among authors: zambon m. Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30179. Euro Surveill. 2016. PMID: 27074651 Free article.
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
Pebody RG, Whitaker H, Ellis J, Andrews N, Marques DFP, Cottrell S, Reynolds AJ, Gunson R, Thompson C, Galiano M, Lackenby A, Robertson C, O'Doherty MG, Owens K, Yonova I, Shepherd SJ, Moore C, Johnston J, Donati M, McMenamin J, Lusignan S, Zambon M. Pebody RG, et al. Among authors: zambon m. Vaccine. 2020 Jan 16;38(3):489-497. doi: 10.1016/j.vaccine.2019.10.071. Epub 2019 Nov 1. Vaccine. 2020. PMID: 31685296 Free article.
Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
Cole ME, Kundu R, Abdulla AF, Andrews N, Hoschler K, Southern J, Jackson D, Miller E, Zambon M, Turner PJ, Tregoning JS. Cole ME, et al. Among authors: zambon m. Clin Exp Immunol. 2021 Apr;204(1):125-133. doi: 10.1111/cei.13564. Epub 2021 Jan 13. Clin Exp Immunol. 2021. PMID: 33314126 Free PMC article. Clinical Trial.
620 results